Public Consultation On Implementation Of Bioequivalence (BE) Study Requirements For New Drug Products Containing Scheduled Poison

User Rating: 4 / 5

Star ActiveStar ActiveStar ActiveStar ActiveStar Inactive
 

 

Online public engagement is in line with the government's aspiration to support the principles of transparency and equality for the implementation of a law.

Therefore, this page is available for public consultation and will present new proposals or amendments to the draft law (including laws, policies, regulations, etc.). The draft will appear on this page for a period of 14 working days.

The public is encouraged to provide comments and views on the National Pharmaceutical Regulatory Agency (NPRA), Ministry of Health Malaysia during this period.

 

 

Feedback/Comment Period : 16/04/2019 - 15/05/2019

 

Slides 

No Document Download
1. Public Consultation On Implementation Of Bioequivalence (BE) Study Requirements For New Drug Products Containing Scheduled Poison Download

 

 

Feedback/Comment Form

No Document Download
1. Comment Form Download

Please email the filled table to Dr Yvonne Khoo ( This email address is being protected from spambots. You need JavaScript enabled to view it. ) by 15 May 2019. 

Thank you for taking time to assist in our efforts towards process improvement.

 

National Pharmaceutical Regulatory Agency (NPRA)
Lot 36, Jalan Universiti, 46200 Petaling Jaya, Selangor, Malaysia.
  • Email: npra@npra.gov.my
  • Phone: +603-7883 5400
  • Fax: +603-7956 2924, +603-7956 7075

DISCLAIMER

The Government of Malaysia and the National Pharmaceutical Regulatory Agency are not responsible for any loss or damage caused by the usage of any information obtained from this website.

Mobile Web :

Newsletter Subsription

Site Last Modified

  • Last Modified: Thursday 12 September 2019, 14:20:55.
© Copyright 2019 . All Rights Reserved National Pharmaceutical Regulatory Agency NPRA

Main Menu English

Choose Your Language